Breakthrough antibody therapy targets Alzheimer’s risk gene, offers hope for effective treatment Post author: Post published:October 6, 2023 Post category:uncategorized Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs). You Might Also Like Recombinant shingles vaccine linked to lower dementia risk, especially in women August 7, 2024 Study finds power-motivated users share more fake news on social media December 20, 2024 Study: 70% of Australians with depression lack adequate treatment November 22, 2024